ZSCAN4
gene geneOn this page
Also known as FLJ35105
Summary
ZSCAN4 (zinc finger and SCAN domain containing 4, HGNC:23709) is a protein-coding gene on chromosome 19q13.43, encoding Zinc finger and SCAN domain-containing protein 4 (Q8NAM6). Embryonic stem (ES) cell-specific transcription factor required to regulate ES cell pluripotency.
The ZSCAN4 gene encodes a protein involved in telomere maintenance and with a key role in the critical feature of mouse embryonic stem (ES) cells, namely, defying cellular senescence and maintaining normal karyotype for many cell divisions in culture (Zalzman et al., 2010 [PubMed 20336070]).
Source: NCBI Gene 201516 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 52 total
- MANE Select transcript:
NM_152677
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23709 |
| Approved symbol | ZSCAN4 |
| Name | zinc finger and SCAN domain containing 4 |
| Location | 19q13.43 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ35105 |
| Ensembl gene | ENSG00000180532 |
| Ensembl biotype | protein_coding |
| OMIM | 613419 |
| Entrez | 201516 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000318203
RefSeq mRNA: 2 — MANE Select: NM_152677
NM_001384833, NM_152677
CCDS: CCDS12958
Canonical transcript exons
ENST00000318203 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001257971 | 57677914 | 57678079 |
| ENSE00001257982 | 57676041 | 57676541 |
| ENSE00001498641 | 57668935 | 57669203 |
| ENSE00001509506 | 57670245 | 57670567 |
| ENSE00001736292 | 57678166 | 57679152 |
Expression profiles
Bgee: expression breadth broad, 85 present calls, max score 69.47.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2044 / max 39.4535, expressed in 75 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 177789 | 0.0883 | 35 |
| 177790 | 0.0723 | 26 |
| 177788 | 0.0324 | 8 |
| 208949 | 0.0114 | 5 |
Top tissues by expression
208 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| epithelium of nasopharynx | UBERON:0001951 | 69.47 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 64.64 | gold quality |
| placenta | UBERON:0001987 | 64.13 | gold quality |
| apex of heart | UBERON:0002098 | 62.96 | gold quality |
| superficial temporal artery | UBERON:0001614 | 62.89 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 61.02 | gold quality |
| mammary duct | UBERON:0001765 | 58.30 | gold quality |
| right uterine tube | UBERON:0001302 | 58.07 | gold quality |
| lower lobe of lung | UBERON:0008949 | 57.40 | silver quality |
| vena cava | UBERON:0004087 | 56.53 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 55.84 | gold quality |
| amniotic fluid | UBERON:0000173 | 55.60 | gold quality |
| skin of abdomen | UBERON:0001416 | 54.34 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 53.71 | gold quality |
| gingival epithelium | UBERON:0001949 | 53.57 | gold quality |
| mammalian vulva | UBERON:0000997 | 53.15 | gold quality |
| biceps brachii | UBERON:0001507 | 52.58 | gold quality |
| vastus lateralis | UBERON:0001379 | 51.43 | gold quality |
| quadriceps femoris | UBERON:0001377 | 51.18 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 50.46 | gold quality |
| zone of skin | UBERON:0000014 | 50.27 | gold quality |
| gingiva | UBERON:0001828 | 49.58 | gold quality |
| urinary bladder | UBERON:0001255 | 49.55 | gold quality |
| skin of leg | UBERON:0001511 | 49.39 | gold quality |
| minor salivary gland | UBERON:0001830 | 49.15 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 48.84 | gold quality |
| mouth mucosa | UBERON:0003729 | 48.80 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 47.92 | gold quality |
| skin of hip | UBERON:0001554 | 47.43 | gold quality |
| body of stomach | UBERON:0001161 | 46.41 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-3929 | yes | 2660.96 |
| E-ANND-3 | no | 3.76 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA1155.1 | ZSCAN4 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:28092692
Upstream regulators (CollecTRI, top): RIF1
miRNA regulators (miRDB)
18 targeting ZSCAN4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4789-5P | 99.98 | 70.76 | 2721 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-659-3P | 99.85 | 70.69 | 1620 |
| HSA-MIR-577 | 99.78 | 69.13 | 2479 |
| HSA-MIR-6505-5P | 99.73 | 69.25 | 1595 |
| HSA-MIR-8084 | 99.73 | 69.57 | 1760 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-7159-5P | 99.53 | 72.12 | 2472 |
| HSA-MIR-888-3P | 99.53 | 69.77 | 1057 |
| HSA-MIR-5689 | 99.50 | 71.26 | 1154 |
| HSA-MIR-4696 | 99.48 | 67.48 | 1040 |
| HSA-MIR-3606-5P | 99.31 | 69.67 | 1168 |
| HSA-MIR-421 | 98.90 | 67.04 | 1883 |
| HSA-MIR-4272 | 98.76 | 68.74 | 1810 |
| HSA-MIR-5581-3P | 98.55 | 70.31 | 1161 |
| HSA-MIR-4768-3P | 98.16 | 66.02 | 2330 |
| HSA-MIR-625-3P | 97.32 | 66.55 | 554 |
| HSA-MIR-3935 | 96.33 | 66.79 | 797 |
Literature-anchored findings (GeneRIF, showing 10)
- The direct interaction between Zscan4 and Rap1 may explain how Zscan4 rapidly increases telomere length, yielding important information about the role of these proteins in telomere biology. (PMID:24840609)
- ZSCAN4 indirectly interacts with TRF1 in cancer cells. We show that ZSCAN4 plays an important role independent of telomere maintenance pathways (telomerase positive and alternative pathway) or cell lineage. (PMID:26403970)
- the expression and function of each gene copy of Zscan4 locus in a physiological context, is reported. (PMID:27699651)
- Zscan4 may play critical roles during late meiotic prophase in both males and females. (PMID:27699653)
- RNF20 depletion stabilizes the ZSCAN4 protein half-life, suggesting that RNF20 negatively regulates ZSCAN4 stability. (PMID:29477841)
- The senescence-associated secretory phenotype is potentiated by feedforward regulatory mechanisms involving Zscan4 and TAK1. (PMID:29712904)
- ZSCAN4 facilitates chromatin remodeling and promotes the cancer stem cell phenotype. (PMID:32507861)
- The Zscan4-Tet2 Transcription Nexus Regulates Metabolic Rewiring and Enhances Proteostasis to Promote Reprogramming. (PMID:32668244)
- Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of upper urinary tract and urinary bladder. (PMID:36841776)
- ZSCAN4-binding motif-TGCACAC is conserved and enriched in CA/TG microsatellites in both mouse and human genomes. (PMID:38153767)
Cross-species orthologs
0 orthologs
Paralogs (30): ZNF263 (ENSG00000006194), ZNF213 (ENSG00000085644), ZNF500 (ENSG00000103199), ZKSCAN1 (ENSG00000106261), ZNF205 (ENSG00000122386), ZSCAN9 (ENSG00000137185), PGBD1 (ENSG00000137338), ZNF215 (ENSG00000149054), ZSCAN12 (ENSG00000158691), ZNF394 (ENSG00000160908), ZNF75A (ENSG00000162086), ZSCAN21 (ENSG00000166529), ZNF232 (ENSG00000167840), ZNF24 (ENSG00000172466), ZNF449 (ENSG00000173275), ZSCAN22 (ENSG00000182318), ZNF75D (ENSG00000186376), ZNF396 (ENSG00000186496), ZNF397 (ENSG00000186812), ZSCAN30 (ENSG00000186814), ZKSCAN4 (ENSG00000187626), ZSCAN23 (ENSG00000187987), ZKSCAN3 (ENSG00000189298), ZSCAN16 (ENSG00000196812), ZSCAN25 (ENSG00000197037), ZSCAN26 (ENSG00000197062), ZNF165 (ENSG00000197279), ZKSCAN8 (ENSG00000198315), ZSCAN31 (ENSG00000235109), ZNF853 (ENSG00000236609)
Protein
Protein identifiers
Zinc finger and SCAN domain-containing protein 4 — Q8NAM6 (reviewed: Q8NAM6)
Alternative names: Zinc finger protein 494
All UniProt accessions (1): Q8NAM6
UniProt curated annotations — full annotation on UniProt →
Function. Embryonic stem (ES) cell-specific transcription factor required to regulate ES cell pluripotency. Binds telomeres and plays a key role in genomic stability in ES cells by regulating telomere elongation. Acts as an activator of spontaneous telomere sister chromatid exchange (T-SCE) and telomere elongation in undifferentiated ES cells.
Subcellular location. Nucleus. Chromosome. Telomere.
RefSeq proteins (2): NP_001371762, NP_689890* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003309 | SCAN_dom | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR038269 | SCAN_sf | Homologous_superfamily |
Pfam: PF00096, PF02023
UniProt features (12 total): zinc finger region 4, compositionally biased region 3, region of interest 2, chain 1, domain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NAM6-F1 | 51.09 | 0.08 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9819196 | Zygotic genome activation (ZGA) |
MSigDB gene sets: 36 (showing top):
GOBP_CHROMOSOME_ORGANIZATION, GOBP_REGULATION_OF_DNA_RECOMBINATION, GOBP_NEGATIVE_REGULATION_OF_DNA_RECOMBINATION, GOBP_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING, GOBP_TELOMERE_ORGANIZATION, GOBP_MITOTIC_RECOMBINATION, GOCC_CHROMOSOMAL_REGION, GOCC_CHROMOSOME_TELOMERIC_REGION, GOBP_DNA_METABOLIC_PROCESS, GOBP_DNA_RECOMBINATION, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_DNA_METABOLIC_PROCESS, GOBP_REGULATION_OF_MITOTIC_RECOMBINATION, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, MADAN_DPPA4_TARGETS
GO Biological Process (3): regulation of transcription by RNA polymerase II (GO:0006357), telomere maintenance via telomere lengthening (GO:0010833), negative regulation of mitotic recombination (GO:0045950)
GO Molecular Function (8): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677), protein binding (GO:0005515), sequence-specific DNA binding (GO:0043565), metal ion binding (GO:0046872)
GO Cellular Component (3): chromosome, telomeric region (GO:0000781), nucleus (GO:0005634), chromosome (GO:0005694)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Maternal to zygotic transition (MZT) | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| telomere maintenance | 1 |
| regulation of mitotic recombination | 1 |
| mitotic recombination | 1 |
| negative regulation of DNA recombination | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| DNA binding | 1 |
| cation binding | 1 |
| chromosomal region | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
712 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZSCAN4 | TRIM43 | Q96BQ3 | 773 |
| ZSCAN4 | DUX4L2 | P0CJ85 | 768 |
| ZSCAN4 | MBD3L2 | Q8NHZ7 | 762 |
| ZSCAN4 | LEUTX | A8MZ59 | 667 |
| ZSCAN4 | PRAMEF1 | O95521 | 660 |
| ZSCAN4 | UBTFL1 | P0CB47 | 624 |
| ZSCAN4 | DPPA2 | Q7Z7J5 | 623 |
| ZSCAN4 | SMCHD1 | A6NHR9 | 587 |
| ZSCAN4 | TMEM92 | Q6UXU6 | 586 |
| ZSCAN4 | KHDC1L | Q5JSQ8 | 581 |
| ZSCAN4 | DUXA | A6NLW8 | 579 |
| ZSCAN4 | KHDC1 | Q4VXA5 | 578 |
| ZSCAN4 | DPPA4 | Q7L190 | 571 |
| ZSCAN4 | NANOG | Q9H9S0 | 524 |
| ZSCAN4 | RFPL2 | O75678 | 522 |
IntAct
41 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KAT5 | ZSCAN4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CIB3 | ZSCAN4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CTBP2 | ZSCAN4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PARD6B | ZSCAN4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZSCAN4 | EXOC8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HCK | ZSCAN4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TBC1D22B | ZSCAN4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM110A | ZSCAN4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRAF3 | ZSCAN4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZSCAN4 | LAMTOR3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZSCAN4 | KAT5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HAT1 | ZSCAN4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZSCAN4 | CIB3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZSCAN4 | PARD6B | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZSCAN4 | TBC1D22B | psi-mi:“MI:0915”(physical association) | 0.560 |
| EXOC8 | ZSCAN4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZSCAN4 | FAM110A | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZSCAN4 | psi-mi:“MI:0915”(physical association) | 0.370 | |
| TNF | ZSCAN4 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TNFSF14 | ZSCAN4 | psi-mi:“MI:0915”(physical association) | 0.370 |
BioGRID (17): RNF20 (Affinity Capture-Western), RNF20 (Co-localization), ZSCAN4 (Two-hybrid), ZSCAN4 (Two-hybrid), ZSCAN4 (Two-hybrid), ZSCAN4 (Two-hybrid), ZSCAN4 (Two-hybrid), ZSCAN4 (Two-hybrid), ZSCAN4 (Two-hybrid), ZSCAN4 (Two-hybrid), ZSCAN4 (Two-hybrid), ZSCAN4 (Two-hybrid), ZSCAN4 (Two-hybrid), ZNF217 (Affinity Capture-MS), ZSCAN4 (Two-hybrid)
ESM2 similar proteins: A0A1B0GTS1, A0A1B0GWH4, A1A4L6, A1YGI6, A6NDR6, B8QB46, F1MJR8, F1QDF8, O35892, O35893, P09015, P15036, P15037, P23497, P52729, P59598, Q32NH9, Q3KRF1, Q3UM89, Q4G112, Q4V7E1, Q5M7N6, Q5ND04, Q5XIV2, Q5ZHX5, Q66IG8, Q6P1R3, Q6PCX9, Q6PJQ5, Q708W2, Q76I76, Q76I79, Q76N89, Q7M6U3, Q8AXQ4, Q8BVK9, Q8IUE0, Q8IUE1, Q8IWB6, Q8IXJ9
Diamond homologs: A1YEP8, A1YFW2, A1YFX5, A1YG60, A1YGJ4, A2T6E3, A2T6V8, A2T736, A2T7D7, A2T7F4, A2T7G6, A6QNZ0, A7KBS4, D2HQI1, O14978, O15535, O43309, O60304, P0CG00, P10073, P17028, P49910, Q15697, Q15776, Q16670, Q1LZ87, Q3MJ62, Q3URS2, Q4R8H9, Q5RAE6, Q5RJ54, Q5SXI5, Q6NSZ9, Q6R2W3, Q80VJ6, Q86W11, Q8BGS3, Q8CF60, Q8IWY8, Q8N0Y2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
52 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 44 |
| Likely benign | 6 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
557 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:57676039:A:AG | acceptor_gain | 1.0000 |
| 19:57676040:G:GC | acceptor_loss | 1.0000 |
| 19:57676040:G:GG | acceptor_gain | 1.0000 |
| 19:57676538:CTTA:C | donor_gain | 1.0000 |
| 19:57676539:TTA:T | donor_gain | 1.0000 |
| 19:57676540:TA:T | donor_gain | 1.0000 |
| 19:57676540:TAGT:T | donor_loss | 1.0000 |
| 19:57676541:AG:A | donor_loss | 1.0000 |
| 19:57676542:G:GG | donor_gain | 1.0000 |
| 19:57677909:TACA:T | acceptor_loss | 1.0000 |
| 19:57677912:A:AC | acceptor_loss | 1.0000 |
| 19:57677912:A:AG | acceptor_gain | 1.0000 |
| 19:57677913:G:GG | acceptor_gain | 1.0000 |
| 19:57678164:A:AG | acceptor_gain | 1.0000 |
| 19:57678165:G:GG | acceptor_gain | 1.0000 |
| 19:57676040:GC:G | acceptor_gain | 0.9900 |
| 19:57676040:GCTT:G | acceptor_gain | 0.9900 |
| 19:57676537:CCTTA:C | donor_gain | 0.9900 |
| 19:57676543:TG:T | donor_loss | 0.9900 |
| 19:57676544:GAGT:G | donor_loss | 0.9900 |
| 19:57676545:AGTA:A | donor_loss | 0.9900 |
| 19:57677913:GGT:G | acceptor_gain | 0.9900 |
| 19:57677913:GGTC:G | acceptor_gain | 0.9900 |
| 19:57677913:GGTCC:G | acceptor_gain | 0.9900 |
| 19:57678078:AGGTA:A | donor_loss | 0.9900 |
| 19:57678080:G:A | donor_loss | 0.9900 |
| 19:57678081:T:G | donor_loss | 0.9900 |
| 19:57678160:TCACA:T | acceptor_loss | 0.9900 |
| 19:57678161:CACAG:C | acceptor_loss | 0.9900 |
| 19:57678163:C:CG | acceptor_loss | 0.9900 |
AlphaMissense
2873 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:57678732:T:C | F377L | 1.000 |
| 19:57678734:C:A | F377L | 1.000 |
| 19:57678734:C:G | F377L | 1.000 |
| 19:57678795:T:C | C398R | 1.000 |
| 19:57678564:T:C | F321L | 0.999 |
| 19:57678566:T:A | F321L | 0.999 |
| 19:57678566:T:G | F321L | 0.999 |
| 19:57678627:T:C | C342R | 0.999 |
| 19:57678648:T:C | F349L | 0.999 |
| 19:57678650:C:A | F349L | 0.999 |
| 19:57678650:C:G | F349L | 0.999 |
| 19:57678667:T:C | L355P | 0.999 |
| 19:57678711:T:C | C370R | 0.999 |
| 19:57678713:C:G | C370W | 0.999 |
| 19:57678720:T:C | C373R | 0.999 |
| 19:57678733:T:C | F377S | 0.999 |
| 19:57678797:T:G | C398W | 0.999 |
| 19:57678804:T:C | C401R | 0.999 |
| 19:57678806:T:G | C401W | 0.999 |
| 19:57678816:T:G | Y405D | 0.999 |
| 19:57678834:T:G | Y411D | 0.999 |
| 19:57678841:G:C | R413P | 0.999 |
| 19:57678552:T:C | C317R | 0.998 |
| 19:57678675:C:G | H358D | 0.998 |
| 19:57678679:A:C | Q359P | 0.998 |
| 19:57678705:T:C | F368L | 0.998 |
| 19:57678707:C:A | F368L | 0.998 |
| 19:57678707:C:G | F368L | 0.998 |
| 19:57678720:T:A | C373S | 0.998 |
| 19:57678721:G:C | C373S | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000170822 (19:57664202 A>C), RS1000342500 (19:57657954 G>T), RS1000360902 (19:57679160 G>A,C), RS1000576195 (19:57667913 T>C), RS1000587331 (19:57650612 A>G), RS1000595984 (19:57673586 G>A), RS1000627028 (19:57657563 G>A), RS1000809665 (19:57664203 G>A), RS1000928419 (19:57664437 G>T), RS1001013263 (19:57662151 T>C), RS1001246855 (19:57656457 C>A,T), RS1001292116 (19:57655126 C>T), RS1001326834 (19:57676888 C>T), RS1001369358 (19:57667955 G>T), RS1001381334 (19:57670075 G>A)
Disease associations
OMIM: gene MIM:613419 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases expression, increases methylation | 5 |
| Aflatoxin B1 | affects expression, increases expression, increases methylation | 4 |
| TAK-243 | increases sumoylation | 1 |
| ethyl-p-hydroxybenzoate | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Decitabine | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Endosulfan | increases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Fenfluramine | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Naled | affects expression | 1 |
| Quercetin | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
| Okadaic Acid | increases expression | 1 |
Cellosaurus cell lines
4 cell lines: 3 embryonic stem cell, 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_A8K9 | SEES3-1V human ZSCAN4, clone1 | Embryonic stem cell | Male |
| CVCL_A8L0 | SEES3-1V human ZSCAN4, clone2 | Embryonic stem cell | Male |
| CVCL_A8L1 | SEES3-1V human ZSCAN4, clone3 | Embryonic stem cell | Male |
| CVCL_HD49 | HEK293 eGFP-ZSCAN4 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.